Company Profile

Serotiny Inc
Profile last edited on: 9/23/20      CAGE: 78UJ9      UEI:

Business Identifier: Multi-domain biotherapeutic proteins for use in cell-, gene-, and immune- therapies
Year Founded
2014
First Award
2016
Latest Award
2016
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

953 Indiana Street
San Francisco, CA 94107
   (317) 650-1988
   info@serotiny.bio
   serotiny.bio
Location: Single
Congr. District: 12
County: San Francisco

Public Profile

The word ‘serotiny’ means the ecological adaptation by some plants to have their seeds germinate upon a particular environmental trigger; an example would be fire. Currently resident in the JLab San Francisco, Serotiny is structured digitally to encode nature’s features and functions into a biologically aware API for the high-throughput, rational design of multi-domain synthetic proteins. The premise is that by coupling state-of-the-art mammalian synthetic biology and a finely-tuned software architecture, and in partnership with leaders in the field, Serotiny can tackle design of custom proteins with cutting edge capabilities including treatment of cancers and genetic disorders. The objective is to make better therapies and tools by designing multi-domain proteins with novel functionality: tailoring protein designs for unique demands including treatment of cancers and genetic disorders. The approach has to potential to give proteins wholly new functions for more effective, safer, and customized ther

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2016 1 NSF $149,960
Project Title: Software for High-Throughput Combinatorial Design and Curation of Novel Proteins

Key People / Management

  Colin Farlow -- Founder

  Justin Farlow -- Founder

Company News

There are no news available.